Pacira BioSciences, Inc. (PCRX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 250M 500M 750M FY09: 15M FY10: 14.6M FY11: 15.7M FY12: 39.1M FY13: 85.6M FY14: 197.7M FY15: 249M FY16: 270.1M FY17: 284.3M FY18: 332.4M FY19: 418.9M FY20: 429.6M FY21: 541.5M FY22: 666.8M FY23: 675M FY24: 701M FY25: 726.4M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

-200M 0 200M 400M 600M FY09: 2.7M FY10: 2.3M FY11: -1.1M FY12: 6.9M FY13: 30.8M FY14: 120.2M FY15: 177.2M FY16: 160M FY17: 196.4M FY18: 245.6M FY19: 312.2M FY20: 312.3M FY21: 401.3M FY22: 467.5M FY23: 490.3M FY24: 530.5M FY25: 576.7M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

-105M -70M -35M 0 35M 70M 105M FY09: -28.5M FY10: -22.7M FY11: -39.1M FY12: -49.3M FY13: -53.3M FY14: -5.2M FY15: 9.5M FY16: -32M FY17: -24.9M FY18: 15.9M FY19: 10.5M FY20: 46.4M FY21: 89.9M FY22: 60M FY23: 87.7M FY24: -73.4M FY25: 19.2M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-100M -50M 0 50M 100M 150M FY09: -31.7M FY10: -27.1M FY11: -43.3M FY12: -52.3M FY13: -63.9M FY14: -13.7M FY15: 1.9M FY16: -37.9M FY17: -42.6M FY18: -471K FY19: -11M FY20: 145.5M FY21: 42M FY22: 15.9M FY23: 42M FY24: -99.6M FY25: 7M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 70M 140M 210M FY09: 12.3M FY10: 12.3M FY11: 16.7M FY12: 32.1M FY13: 54.8M FY14: 77.4M FY15: 71.8M FY16: 110.1M FY17: 87.9M FY18: 86.8M FY19: 106.7M FY20: 117.3M FY21: 140.3M FY22: 199.3M FY23: 184.7M FY24: 170.4M FY25: 149.7M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

-140M -70M 0 70M 140M 210M FY09: -20.8M FY10: -24.9M FY11: -31M FY12: -70.1M FY13: -43.8M FY14: 26.6M FY15: 28M FY16: 33.5M FY17: 17.8M FY18: 48.9M FY19: 70.5M FY20: 77M FY21: 125.7M FY22: 145.3M FY23: 154.6M FY24: 189.4M FY25: 152M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-140M -70M 0 70M 140M 210M FY09: -26.3M FY10: -31.6M FY11: -37.2M FY12: -88.4M FY13: -56M FY14: 3.6M FY15: -12.3M FY16: 8.7M FY17: -1.5M FY18: 34.4M FY19: 60.4M FY20: 39.2M FY21: 79.9M FY22: 115.2M FY23: 139.5M FY24: 178.8M FY25: 136.7M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 20M 40M 60M FY09: 573.1K FY10: 574.1K FY11: 16.4M FY12: 30.3M FY13: 33.2M FY14: 35.3M FY15: 41.3M FY16: 37.2M FY17: 39.8M FY18: 40.9M FY19: 41.5M FY20: 43.7M FY21: 45.6M FY22: 46.5M FY23: 52M FY24: 46.2M FY25: 45M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-60.00 -40.00 -20.00 0.00 20.00 40.00 60.00 Q4 '10: -47.29 Q1 '11: -38.88 Q2 '11: -27.53 Q3 '11: -14.31 Q4 '11: -2.79 Q1 '12: -2.28 Q2 '12: -2.04 Q3 '12: -1.98 Q4 '12: -1.73 Q1 '13: -1.97 Q2 '13: -2.12 Q3 '13: -2.07 Q4 '13: -1.93 Q1 '14: -1.56 Q2 '14: -1.28 Q3 '14: -0.92 Q4 '14: -0.95 Q1 '15: -0.58 Q2 '15: -0.44 Q3 '15: -0.28 Q4 '15: 0.04 Q1 '16: -0.09 Q2 '16: -0.30 Q3 '16: -0.97 Q4 '16: -1.01 Q1 '17: -1.43 Q2 '17: -1.71 Q3 '17: -1.31 Q4 '17: -1.09 Q1 '18: -0.83 Q2 '18: -0.28 Q3 '18: -0.11 Q4 '18: -0.02 Q1 '19: 0.17 Q2 '19: 0.17 Q3 '19: 0.04 Q4 '19: -0.28 Q1 '20: -0.02 Q2 '20: -0.25 Q3 '20: 2.84 Q4 '20: 3.28 Q1 '21: 3.32 Q2 '21: 3.91 Q3 '21: 1.36 Q4 '22: 0.34 Q1 '23: -0.24 Q2 '23: -0.13 Q3 '23: 0.12 Q4 '23: 0.83 Q1 '24: 1.45 Q2 '24: 1.33 Q3 '24: -2.01 Q4 '24: -2.15 Q1 '25: -2.24 Q2 '25: -2.74 Q3 '25: 0.49 Q4 '25: 0.15 Q1 '26: 0.12 Q2 '26: 0.35 Q2 '11 Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '21 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.